Semaglutide & Empagliflozin May Treat Obesity-Related Cognitive Impairment (Mouse Study)
Obesity now affects over 650 million adults globally and is a major risk factor for various chronic diseases including cognitive decline and impairment. Recent evidence shows a link between …
Read article